"We need to stop trusting the experts," Kennedy told Tucker Carlson.
Bill isn't buying what the MAHA movement is selling.
Will more technology make America healthier?
The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly limits access to this medication.
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.
"They're going crazy over MAHA," Trump said to cheers at the White House on Thursday.
A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to current vaccines.
If your next glass of milk makes you puke, feel free to blame Kennedy.
The FDA also refused to publicize an outbreak of E. coli, according to a new report.
The annual spring meeting is a critical part of updating the yearly flu shot to match the strains most likely to be circulating in the U.S. come wintertime.
The FDA previously found Musk's company was engaging in "objectionable conditions or practices."
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.
Say farewell to Red No. 3, a dye linked to thyroid cancer in rats and hyperactivity in children.
The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela. The drug's maker, however, claims that it remains safe and effective.
New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health adverse effects linked to its use.
Brushing your teeth with bacteria just isn't the ideal formula for dental health.
Sometimes it takes a little chemical inspiration to send you in the right direction.
The FDA has just authorized the first at-home, over-the-counter test for syphilis, developed by NOWDiagnostics.
Cresilon Inc's Traumagel has been cleared by the FDA as an emergency treatment to control moderate to severe bleeding.
